DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sandborn WJ, Colombel JF, Panes J et al.
Higher remission and maintenance of response rates with subcutaneous monthly certolizumab pegol in patients with recent-onset Crohn‘s disease: data from precise 2.
Am J Gastroenterol 2006;
101: 434-435
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.